aucubin has been researched along with Lung Injury, Acute in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, F; Cheng, XN; Fang, LY; Hu, HZ; Qiu, YL; Sun, DQ | 1 |
Guan, C; Guo, Q; Kong, G; Li, P; Pan, B; Zhou, Y | 1 |
2 other study(ies) available for aucubin and Lung Injury, Acute
Article | Year |
---|---|
Aucubin protects against lipopolysaccharide-induced acute pulmonary injury through regulating Nrf2 and AMPK pathways.
Topics: Acute Lung Injury; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Antioxidants; Cytokines; Cytoprotection; Disease Models, Animal; Humans; Inflammation Mediators; Iridoid Glucosides; Lipopolysaccharides; Lung; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-E2-Related Factor 2; Oxidative Stress; Phosphorylation; RAW 264.7 Cells; Signal Transduction; THP-1 Cells; Time Factors | 2018 |
[Aucubin alleviates lipopolysaccharide-induced acute lung injury in mice].
Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Iridoid Glucosides; Lipopolysaccharides; Lung; Male; Mice; Tumor Necrosis Factor-alpha | 2019 |